Chang Carmen

Chang Carmen is listed in filings as 10% Owner at Trevi Therapeutics, Inc.. This profile follows SEC Form 4 activity through Mar 12, 2026, including purchase activity. Recent filings connect the profile to Trevi Therapeutics, Inc. (TRVI), Korro Bio, Inc. (KRRO), and Coursera, Inc. (COUR). The current snapshot covers public activity from May 23, 2025 to Mar 12, 2026. Reported amounts are shown as $2.5M to $2.3M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.